Precision Medicine Market

Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024

Precision Medicine Market Segmented by Next Generation Sequencing, Bioinformatics, Drug Discovery Technologies in Oncology, Immunology, Neurology, Cardiology, Infectious Disease, and Genomics, Transcriptomics and Epigenomics in Technology, Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing and Nanopore Sequencing in Sequencing Technology and Consumables, Instruments and Services by Product

  • December-2016
  • PMRREP12646
  • 169 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Global Precision Medicine Market Analysis Scenario
   3.1. Market Size (US$ Mn) and Forecast
        3.1.1. Market Size and Y-o-Y Growth
        3.1.2. Absolute $ Opportunity
   3.2. Market Overview

4. Market Dynamics
   4.1. Macro-economic Factors
   4.2. Drivers
        4.2.1. Supply Side
        4.2.2. Demand Side
   4.3. Restraints
   4.4. Opportunity
   4.5. Forecast Factors – Relevance and Impact
   4.6. Technology Advancement 
   4.7. Application Expansion 
   4.8. Research Funding 

5. Global Precision Medicine Market Analysis and Forecasts, By Technology 
   5.1. Introduction
   5.2. Basis Point Share (BPS) Analysis By Technology Type
   5.3. Y-o-Y Growth Projections By Technology Type
   5.4. Market value Forecast By Technology, 2016–2024
        5.4.1. NGS 
        5.4.2. Drug Discovery Technologies 
        5.4.3. Bioinformatics 
   5.5. Prominent Trends
   5.6. Market Attractiveness By Technology 

6. Global Precision Medicine Market Analysis and Forecasts, By Application 
   6.1. Introduction
   6.2. Basis Point Share (BPS) Analysis By Application 
   6.3. Y-o-Y Growth Projections By Application 
   6.4. Market value Forecast By Application, 2016–2024
        6.4.1. Oncology 
        6.4.2. Immunology 
        6.4.3. Neurology 
        6.4.4. Cardiology 
        6.4.5. Infectious Diseases 
        6.4.6. Others 
   6.5. Prominent Trends
   6.6. Market Attractiveness By Application 

7. Global Precision Medicine Market Analysis and Forecasts, By Region
   7.1. Basis Point Share (BPS) Analysis By Region
   7.2. Y-o-Y Growth Projections By Region
   7.3. Market value Forecast By Region
        7.3.1. North America 
        7.3.2. Latin America 
        7.3.3. Europe 
        7.3.4. Asia Pacific 
        7.3.5. Middle East and Africa 
   7.4. Market Attractiveness By Region

8. North America Precision Medicine Market Analysis and Forecast
   8.1. Introduction
        8.1.1. Basis Point Share (BPS) Analysis By Country
        8.1.2. Y-o-Y Growth Projections By Country
        8.1.3. Key Regulations
   8.2. Market value Forecast By Technology, 2016–2024
        8.2.1. NGS 
        8.2.2. Drug Discovery Technologies 
        8.2.3. Bioinformatics 
   8.3. Market value Forecast By Application, 2016–2024
        8.3.1. Oncology 
        8.3.2. Immunology 
        8.3.3. Neurology 
        8.3.4. Cardiology 
        8.3.5. Infectious Diseases 
        8.3.6. Others 
   8.4. Market value Forecast By Country, 2016–2024
        8.4.1. U.S.
        8.4.2. Canada
   8.5. Market Attractiveness Analysis 
        8.5.1. By Technology 
        8.5.2. By Application 
        8.5.3. By Country
   8.6. Prominent Trends 
   8.7. Drivers and Restraints: Impact Analysis 

9. Latin America Precision Medicine Market Analysis and Forecast
   9.1. Introduction
        9.1.1. Basis Point Share (BPS) Analysis By Country
        9.1.2. Y-o-Y Growth Projections By Country
        9.1.3. Key Regulations
   9.2. Market value Forecast By Technology, 2016–2024
        9.2.1. NGS 
        9.2.2. Drug Discovery Technologies 
        9.2.3. Bioinformatics 
   9.3. Market value Forecast By Application, 2016–2024
        9.3.1. Oncology 
        9.3.2. Immunology 
        9.3.3. Neurology 
        9.3.4. Cardiology 
        9.3.5. Infectious Diseases 
        9.3.6. Others 
   9.4. Market value Forecast By Country, 2016–2024
        9.4.1. Brazil
        9.4.2. Mexico
        9.4.3. Rest of Latin America
   9.5. Market Attractiveness Analysis 
        9.5.1. By Technology 
        9.5.2. By Application 
        9.5.3. By Country
   9.6. Prominent Trends 
   9.7. Drivers and Restraints: Impact Analysis 

10. Europe Precision Medicine Market Analysis and Forecast
   10.1.Introduction
        10.1.1. Basis Point Share (BPS) Analysis By Country
        10.1.2. Y-o-Y Growth Projections By Country
        10.1.3. Key Regulations
   10.2.Market value Forecast By Technology, 2016–2024
        10.2.1. NGS 
        10.2.2. Drug Discovery Technologies 
        10.2.3. Bioinformatics 
   10.3.Market value Forecast By Application, 2016–2024
        10.3.1. Oncology 
        10.3.2. Immunology 
        10.3.3. Neurology 
        10.3.4. Cardiology 
        10.3.5. Infectious Diseases 
        10.3.6. Others 
   10.4.Market value Forecast By Country, 2016–2024
        10.4.1. U.K.
        10.4.2. France
        10.4.3. Germany
        10.4.4. Italy
        10.4.5. Spain
        10.4.6. Rest of Europe
   10.5.Market Attractiveness Analysis 
        10.5.1. By Technology 
        10.5.2. By Application 
        10.5.3. By Country
   10.6. Prominent Trends 
   10.7. Drivers and Restraints: Impact Analysis 

11. Asia Pacific Precision Medicine Market Analysis and Forecast
   11.1.Introduction
        11.1.1. Basis Point Share (BPS) Analysis By Country
        11.1.2. Y-o-Y Growth Projections By Country
        11.1.3. Key Regulations
   11.2.Market value Forecast By Technology, 2016–2024
        11.2.1. NGS 
        11.2.2. Drug Discovery Technologies 
        11.2.3. Bioinformatics 
   11.3.Market value Forecast By Application, 2016–2024
        11.3.1. Oncology 
        11.3.2. Immunology 
        11.3.3. Neurology 
        11.3.4. Cardiology 
        11.3.5. Infectious Diseases 
        11.3.6. Others 
   11.4.Market value Forecast By Country, 2016–2024
        11.4.1. Japan
        11.4.2. China
        11.4.3. India
        11.4.4. Australia
        11.4.5. New Zealand 
        11.4.6. Rest of Asia Pacific
   11.5.Market Attractiveness Analysis 
        11.5.1. By Technology 
        11.5.2. By Application 
        11.5.3. By Country
   11.6. Prominent Trends 
   11.7. Drivers and Restraints: Impact Analysis 

12. Middle East and Africa Precision Medicine Market Analysis and Forecast
   12.1.Introduction
        12.1.1. Basis Point Share (BPS) Analysis By Country
        12.1.2. Y-o-Y Growth Projections By Country
        12.1.3. Key Regulations
   12.2.Market value Forecast By Technology, 2016–2024
        12.2.1. NGS 
        12.2.2. Drug Discovery Technologies 
        12.2.3. Bioinformatics 
   12.3.Market value Forecast By Application, 2016–2024
        12.3.1. Oncology 
        12.3.2. Immunology 
        12.3.3. Neurology 
        12.3.4. Cardiology 
        12.3.5. Infectious Diseases 
        12.3.6. Others 
   12.4.Market value Forecast By Country, 2016–2024
        12.4.1. GCC Countries
        12.4.2. South Africa
        12.4.3. Saudi Arabia 
        12.4.4. Rest of MEA
   12.5.Market Attractiveness Analysis 
        12.5.1. By Technology 
        12.5.2. By Application 
        12.5.3. By Country
   12.6. Prominent Trends 
   12.7. Drivers and Restraints: Impact Analysis 

13. Competition Landscape
   13.1. Competition Dashboard
   13.2. Market Share Analysis By Company (2015)
   13.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
        13.3.1. F. Hoffmann-La Roche AG 
        13.3.2. Illumina, Inc. 
        13.3.3. Thermo Fisher Scientific Inc. 
        13.3.4. QIAGEN
        13.3.5. Quest Diagnostics 
        13.3.6. Laboratory Corporation of America Holdings 
        13.3.7. Novartis AG 
        13.3.8. AstraZeneca 
        13.3.9. Bristol-Myers Squibb 
        13.3.10. Eli Lilly And Company 

14. Assumptions and Acronyms Used

15. Research Methodology

Find Out More about the Report Coverage

List of Tables

List of Tables

Table 01: Global Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016–2024
Table 02: Global Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016–2024
Table 03: Global Precision Medicine Market Size (US$ Mn) Forecast: by Region, 2016–2024
Table 04: North America Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016–2024
Table 05: North America Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016–2024
Table 06: North America Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016–2024
Table 07: Europe Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016–2024
Table 08: Europe Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016–2024
Table 09: Europe Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016–2024
Table 10: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016–2024
Table 11: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016–2024
Table 12: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016–2024
Table 13: Latin America Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016–2024
Table 14: Latin America Precision Medicine Market Size (US$ Mn) Forecast: by Application, 2016–2024
Table 15: Latin America Precision Medicine Market Size (US$ Mn): by Country, 2016–2024
Table 16: Middle East & Africa Precision Medicine Market Size (US$ Mn) Forecast: by Technology, 2016–2024
Table 17: Middle East & Africa Precision Medicine Market Value (US$ Mn) Forecast: by Application, 2016–2024
Table 18: Middle East & Africa Precision Medicine Market Size (US$ Mn) Forecast: by Country, 2016–2024

 

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

List of Figures

Figure 01: Global Precision Medicine (US$ Mn) Forecast, 2016–2024
Figure 02: Global Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 03: Global Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
Figure 04: Global NGS Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 05: Global Drug Discovery Technologies Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 06: Global Bioinformatics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 07: Global Precision Medicine Market Attractiveness Analysis: by Technology 
Figure 08: Global Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
Figure 09: Global Oncology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 10: Global Immunology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 11: Global Neurology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 12: Global Cardiology Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 13: Global Infectious Disease Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 14: Global Others Market Value (US$ Mn) and Y-o-Y Growth (%), 2016–2024
Figure 15: Global Precision Medicine Market Attractiveness Analysis: by Application
Figure 16: Global Precision Medicine Market Value Share Analysis, by Region, 2016 and 2024
Figure 17: Global Precision Medicine Market Attractiveness Analysis, by Region
Figure 18: North America Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 19: North America Precision Medicine Market Size and Y-o-Y Growth Projections, 2016–2024
Figure 20: North America Precision Medicine Market Attractiveness Analysis, by Country
Figure 21: North America Precision Medicine Market Value Share Analysis, by Technology, 2016 and 2024
Figure 22: North America Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
Figure 23: North America Precision Medicine Market Value Share Analysis: by Country, 2016 and 2024
Figure 24: The U.S. Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 25: The U.S. Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 26: Canada Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 27: Canada Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 28: North America Precision Medicine Market Attractiveness Analysis: by Technology, 2016–2024
Figure 29: North America Precision Medicine Market Attractiveness Analysis: by Application, 2016–2024
Figure 30: Europe Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 31: Europe Precision medicine Y-o-Y Growth Projections, 2016–2024
Figure 32: Europe Market Attractiveness Analysis: by Country
Figure 33: Europe Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
Figure 34: Europe Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
Figure 35: Europe Precision Medicine Market Value Share Analysis: by Country, 2016 and 2024
Figure 36: Germany Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 37: Germany Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 38: The U.K. Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 39: The U.K. Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 40: France Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 41: France Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 42: Italy Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 43: Italy Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 44: Spain Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 45: Spain Precision Medicine Market Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 46: Rest of Europe Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 47: Rest of Europe Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 48: Europe Precision Medicine Market Attractiveness Analysis, by Technology Type, 2016–2024
Figure 49: Europe Precision Medicine Market Attractiveness Analysis, by Application, 2016–2024
Figure 50: Asia Pacific Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 51: Asia Pacific Precision Medicine Market Size and Y-o-Y Growth Projections, 2016–2024
Figure 52: Asia Pacific Precision Medicine Market Attractiveness Analysis: by Country, 2016–2024
Figure 53: Asia Pacific Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
Figure 54: Asia Pacific Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
Figure 55: China Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 56: Japan Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 57: Japan Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 58: India Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 59: India Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 60: Australia Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 61: Australia Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 62: New Zealand Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 63: New Zealand Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 64: Rest of APAC Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 65: Rest of APAC Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 66: Asia Pacific Precision Medicine Market Attractiveness Analysis: by Technology, 2016–2024
Figure 67: Asia Pacific Precision Medicine Market Attractiveness Analysis: by Application, 2016–2024
Figure 68: Latin America Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 69: Latin America Precision Medicine Market Size and Y-o-Y Growth Projections, 2016–2024
Figure 70: Latin America Market Attractiveness Analysis, by Country
Figure 71: Latin America Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
Figure 72: Latin America Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
Figure 73: Latin America Market Value Share Analysis: by Country, 2016 and 2024
Figure 74: Brazil Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 75: Brazil Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 76: Mexico Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 77: Mexico Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 78: Rest of LATAM Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 79: Rest of LATAM Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 80: Latin America Precision Medicine Market Attractiveness Analysis: by Technology, 2016–2024
Figure 81: Latin America Precision Medicine Market Attractiveness Analysis: by Application, 2016–2024
Figure 82: MEA Precision Medicine Market Size (US$ Mn) and Volume (Units) Forecast, 2016–2024
Figure 83: MEA Precision Medicine Market Size and Y-o-Y Growth Projections, 2016–2024
Figure 84: MEA Precision Medicine Market Attractiveness Analysis, by Country
Figure 85: Middle East & Africa Precision Medicine Market Value Share Analysis: by Technology, 2016 and 2024
Figure 86: Middle East & Africa Precision Medicine Market Value Share Analysis: by Application, 2016 and 2024
Figure 87: MEA Precision Medicine Market Value Share Analysis: by Country, 2016 and 2024
Figure 88: Saudi Arabia Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 89: Saudi Arabia Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 90: UAE Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 91: UAE Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 92: RSA Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 93: RSA Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 94: Rest of MEA Precision Medicine Market Size (US$ Mn) Forecast, 2016–2024
Figure 95: Rest of MEA Precision Medicine Market, Absolute $ Opportunity (US$ Mn), 2016–2024
Figure 96: MEA Precision Medicine Market Attractiveness Analysis, by Technology, 2016–2024
Figure 97: MEA Precision Medicine Market Attractiveness Analysis, by Application, 2016–2024

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

This Persistence Market Research (PMR) report examines the global precision medicine market for the period 2016–2024. The primary objective of the report is to offer updates and information related to market opportunities in the global precision medicine market.

The report offers an in-depth insight of the global precision medicine market. The report study covers most prominent factors that are impacting the organic growth of the market. The report also gauges the changing trends and talks about new developments that will change the face of the global precision medicine market.

The report is a detailed study of the market strategy adopted the key shareholders of the market. The market insight discusses about some of the major inclusion of smart IT enabled technologies and prominent mergers that will expand the periphery of the market and will enhance the customer outreach of the product. The report gives a forecast of the global precision medicine market. The global precision medicine market is segmented as follows: Precision Medicine market by technology, Precision Medicine market by application and Precision Medicine market by region.

This report covers the global precision medicine market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints and opportunities, which are influencing the growth of the global precision medicine market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights. The next few sections of the report analyse the global precision medicine market based on technology, application, and region and present a comprehensive forecast in terms of value for the next eight years.

Report Methodology

We have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global precision medicine market. Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective.

In order to provide an accurate forecast, we have started by sizing up the current market, which forms the basis of how the global precision medicine market is expected to develop in the future. Critical market data, including the base number and segment splits, has been devised through in-depth secondary research.

This data is then triangulated on the basis of different verticals, considering both supply side and demand side drivers and other dynamics of the various regional markets, along with primary interviews of key stakeholders and industry experts operating in the global precision medicine market.

We have also analyzed the different segments of the global precision medicine market in terms of basis point share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identifying the key trends governing the global precision medicine market.

In the final section of the report on precision medicine market, the global precision medicine market competitive landscape is included to provide report audiences with a dashboard view, to access the key differentiators among the competitor firms. This gives the client a comparative landscape of the various industry participants. Detailed company profiles include company-specific long-term and short-term strategies, key offerings and recent developments in the global precision medicine market.

Recommendations

2 Ethylhexanol Market

South Asia and Pacific and MEA, are estimated to witness a steady growth spurred by rapid economic development. These regions are estimated to hold a prominent share in the 2-ethylhexanol market during the forecast period..

Propylene Glycol Ether Market

The global propylene glycol ether market is estimated to have been valued at US$ 1,604.1 Mn by 2017 end and is expected to reach US$ 2,088.4 Mn by the end of 2026 while expanding at a CAGR of 3.0% over the forecast period. .

Polyol Ester Market

As per PMR's research study, global polyol ester market anticipated to rise at a robust CAGR of 5.1% along with a healthy revenue during the forecast period of 2017-2027.

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

Our Clients

Our Clients